From: Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: a systematic review
hPL manufacturing
N
%
Industrial (I)
9
16.07
Buffy coat (BC)
Platelet-rich plasma (PRP)
15
26.79
Apheresis (Aph)
11
19.64
Apheresis and/or Buffy Coat
2
3.57
Not mentioned (N.M.)
10
17.86